TY - JOUR
T1 - Depression in Parkinson's disease
T2 - Health risks, etiology, and treatment options
AU - Frisina, Pasquale G.
AU - Borod, Joan C.
AU - Foldi, Nancy S.
AU - Tenenbaum, Harriet R.
PY - 2008
Y1 - 2008
N2 - Depression is found in about 30%-40% of all patients with Parkinson's disease (PD), but only a small percentage (about 20%) receive treatment. As a consequence, many PD patients suffer with reduced health-related quality of life. To address quality of life in depressed PD patients, we reviewed the literature on the health correlates of depression in PD (eg, cognitive function), etiology of depression in PD, and treatment options (ie, antidepressants, electroconvulsive therapy, and psychotherapy). The current review is unique in its focus on psychosocial aspects, as well as neuropathological factors, of depression in PD. Overall, we conclude that neurochemical (eg, serotonin) and psychosocial factors (eg, coping style, self-esteem, and social support) contribute to the affective disturbances found in this neuropsychiatric population. Therefore, we recommend that a multidisciplinary (eg, pharmacotherapeutic, psychoeducational, and/or psychotherapeutic) approach to treatment be taken with depressed PD patients.
AB - Depression is found in about 30%-40% of all patients with Parkinson's disease (PD), but only a small percentage (about 20%) receive treatment. As a consequence, many PD patients suffer with reduced health-related quality of life. To address quality of life in depressed PD patients, we reviewed the literature on the health correlates of depression in PD (eg, cognitive function), etiology of depression in PD, and treatment options (ie, antidepressants, electroconvulsive therapy, and psychotherapy). The current review is unique in its focus on psychosocial aspects, as well as neuropathological factors, of depression in PD. Overall, we conclude that neurochemical (eg, serotonin) and psychosocial factors (eg, coping style, self-esteem, and social support) contribute to the affective disturbances found in this neuropsychiatric population. Therefore, we recommend that a multidisciplinary (eg, pharmacotherapeutic, psychoeducational, and/or psychotherapeutic) approach to treatment be taken with depressed PD patients.
KW - Depression
KW - Health outcomes
KW - Parkinson's disease
KW - Treatment options
UR - https://www.scopus.com/pages/publications/41549104140
M3 - Review article
AN - SCOPUS:41549104140
SN - 1178-2021
VL - 4
SP - 81
EP - 91
JO - Neuropsychiatric Disease and Treatment
JF - Neuropsychiatric Disease and Treatment
IS - 1 A
ER -